Dimerization of FGFR2 ligand-independent mutants - Wikidata - wikimedia - TriplyDB

Dimerization of FGFR2 ligand-independent mutants

Dimerization of FGFR2 ligand-independent mutants

http://www.wikidata.org/entity/Q50288700

about

Activated point mutants of FGFR2

P527

Q45314368-7DA4CA53-ED2F-4BC6-999A-A6424E7249BB

P527

Dimerization of FGFR2 ligand-independent mutants

http://www.wikidata.org/entity/Q50288700

description

An instance of the biological ...... endent mutants in Homo sapiens

@en

biologisch proces

@nl

name

Dimerization of FGFR2 ligand-independent mutants

@en

type

label

Dimerization of FGFR2 ligand-independent mutants

@en

prefLabel

Dimerization of FGFR2 ligand-independent mutants

@en

P2860

Q50288700-414EF4E5-A91A-4905-B4B4-D6A789668BB6

Q50288700-4EC33D44-DF42-4EB5-A36B-1F7BB0C1B725

Q50288700-8841B55D-5F5C-47FD-9464-8DCC2F8815DA

Q50288700-88AB7FE8-03B0-401D-87A4-F72D9AF45EF6

Q50288700-AD0909D5-4B46-4771-B4A8-096DE0A8A1F6

Q50288700-B2D4B436-A4DD-4B6C-B4A5-B6A8D7AD22C3

Q50288700-B62F9FD6-0C52-4792-B5A7-F6482DDE74FA

Q50288700-BBC1C605-DC37-4F61-8B47-91AAE61E88B6

Q50288700-D5C5BA50-FD02-460F-A041-B2D0366F466E

Q50288700-E6796B1B-F418-4FF3-8F36-065214BF8E27

P2888

Q50288700-0A87AE21-41C9-4AF3-B154-8778C483F55A

P31

Q50288700-5C8B9F32-FD22-4710-ADA1-F0FC88A23BFC

P361

Q50288700-86038F82-3190-48D5-B3D7-F5C4AD32920B

P3937

Q50288700-2079552D-8268-4E81-BCB6-0C7F8FFF1C23

P527

Q50288700-53133DE2-2DA8-4061-9947-9EC3C6A2E372

Q50288700-A3B3FE2D-2CD3-451B-8B4F-FF9CD08EDB46

P703

Q50288700-754BCD83-EBB5-4C90-B27F-3D36C7A943B7

P2860

Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation.

Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras

Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains

Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type I

Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain

Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand

Patterns of somatic mutation in human cancer genomes

Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes.

Drug-sensitive FGFR2 mutations in endometrial carcinoma

Somatic mutations of the protein kinase gene family in human lung cancer.

P2888

reactome:R-HSA-2029983

P31

biological process

P361

Activated point mutants of FGFR2

P3937

R-HSA-2029983

http://www.w3.org/2001/XMLSchema#string

P527

FGFR2 ligand-independent mutants

FGFR2 ligand-independent mutant dimers

P703